|
Martin, Jack W.
Was Associate Commissioner for Public Affairs at the U.S. Food & Drug Administration.
Later, was vice president for federal relations at Parry, Romani, & DeConcini, and a registered lobbyist for Abbott, American Home Products, Bristol-Myers Squibb, Glaxo-Wellcome, Hoechst Marion Roussel, ICN Pharmaceuticals, Interneuron Pharmaceuticals, Metagenics, Monsanto, Pfizer, Pharmacia & Upjohn, Schering-Plough, and SmithKline Beecham. (1)
Later, formed his own lobbying firm, Walker, Martin & Hatch, which testifies on FDA , (2) on behalf of clients that include Bayer Healthcare, Bio-Technology General Corp, GlaxoSmithKline, and Pharmaceutical Research & Manufacturers of America. (3)
Endnotes:
(1) Consumer Project on Technology, Revolving Door Between the US Government and Industry, Version 2.1, June 2004, http://www.cptech.org/ip/health/politics/revolvingdoor.html
(2) U.S. FDA Public Calendar, June 2, 3002, http://www.fda.gov/bbs/topics/calendar/2003/calendar207.html , accessed Jan 17, 2005
(3) U.S. Senate lobbyist registration website at http://www.senate.gov/pagelayout/legislative/b_three_sections_with_teasers/clientlist_page_W_Z.htm , accessed Jan 17, 2005
|
